Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
종목 코드 NSRX
회사 이름Nasus Pharma Ltd
상장일Aug 13, 2025
CEOTeleman (Dan)
직원 수- -
유형Ordinary Share
회계 연도 종료Aug 13
주소Yigal Alon 65
도시TEL AVIV-YAFO
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가Israel
우편 번호- -
전화97237326616
웹사이트https://www.nasuspharma.com
종목 코드 NSRX
상장일Aug 13, 2025
CEOTeleman (Dan)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음